Instil Bio (TIL) Enterprise Value (2021 - 2026)

Instil Bio has reported Enterprise Value for 6 years, with the latest figure at $46.6 million in Q2 2026.

• On a quarterly basis, Enterprise Value fell 64.93% year-over-year to $46.6 million in Q2 2026; TTM through Jun 2026 was $46.6 million, a 64.93% decrease from a year earlier, with the FY2025 full-year figure at $68.0 million, down 41.3% from the prior year.
• Enterprise Value was $46.6 million for Q2 2026 at Instil Bio, down from $50.9 million in the prior quarter.
• The five-year high for Enterprise Value was $1.0 billion in Q1 2022, with the low at -$179.0 million in Q4 2022.
• Average Enterprise Value over 5 years is $116.0 million, with a median of $66.4 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Enterprise Value slumped 153.31% in 2023, then jumped 438.58% in 2024.
• Over 5 years, Enterprise Value stood at -$179.0 million in 2022, then surged by 43.68% to -$100.8 million in 2023, then surged by 214.86% to $115.8 million in 2024, then sank by 41.3% to $68.0 million in 2025, then sank by 31.42% to $46.6 million in 2026.
• The last three Enterprise Value figures came in at $46.6 million (Q2 2026), $50.9 million (Q1 2026), and $68.0 million (Q4 2025), per Business Quant data.